News

Medtronic Inc. announced the first implants in a clinical trial that will compare patient and healthcare system outcomes — including patient mortality and hospitalizations — in heart failure patients who have cardiac resynchronization therapy (CRT) devices with the AdaptivCRT feature enabled versus patients receiving standard CRT.

Home September 10, 2014
Home
News

Only 25 percent of interviewed ambulatory providers report that meaningful use is having a positive impact on patient care.

Home September 10, 2014
Home
Contrast-Enhanced CT Safe for Most Patients. Patient Dave Fornell.
Feature

September 10, 2014 — According to new research performed at the Mayo Clinic, iodine-based contrast material injected intravenously to enhance computed tomography (CT) images can be safely used in most patients. The study appears online in the journal Radiology.

Home September 10, 2014
Home
News

September 10, 2014 — ResMed announced results from a study presented at the 2014 European Society of Cardiology (ESC) Congress in Barcelona, Spain, looking at the use of the at-home, contactless, bedside SleepMinder device to diagnose sleep-disordered breathing (SDB), the most common co-morbidity in patients with heart failure (HF).

Home September 10, 2014
Home
News

Transcatheter Cardiovascular Therapeutics (TCT) has announced the late-breaking trial presentations at TCT 2014, Sept. 13-17.

Home September 09, 2014
Home
News

September 9, 2014 — Tryton Medical Inc. announced an initial closing of an aggregate $20 million private equity financing. Participating in this financing were existing investors RiverVest Venture Partners and 3x5 Special Opportunity Fund, joined by new investor Canepa Advanced Healthcare Fund and an unnamed investor.

Home September 09, 2014
Home
X0000_SJM_QuadraQuartet_SJMPro (2)_0
Feature

September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease complications at six months, according to preliminary hot line results presented at the 2014 European Society of Cardiology (ESC) Congress in Barcelona.

Home September 09, 2014
Home
News

Claret Medical Inc. vascular and cardiac surgery procedures, announced that it has entered into an agreement for up to $18 million in a Series B financing.

Home September 09, 2014
Home
News

Cook Medical has enrolled the first patient in the clinical study in China of its Zilver PTX Drug Eluting Peripheral Stent. The case was performed by one of the study’s principal investigators, Prof. Peng Liu, M.D., at the China-Japan Friendship Hospital in Beijing.

Home September 09, 2014
Home
News

Community Health Centers (CHCs) across the country, which are the medical home for one in 15 people in the United States, are experiencing an overall increase in patients but fewer uninsured patients in 2014, according to a survey conducted by Direct Relief at the National Association of Community Health Centers (NACHC) annual conference last week. ?

Home September 09, 2014
Home
Technology

September 8, 2014 — Esaote North America announced its new MyLab Six ultrasound system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for sale in the United States.

Home September 08, 2014
Home
Technology

September 8, 2014 — Eizo Inc. expanded its U.S. Food and Drug Administration (FDA) 510(k)-cleared large monitor system with the addition of the RadiForce LS580W monitor and LMM0802 large monitor manager for interventional radiology and surgical suites.

Home September 08, 2014
Home
Case Study

The clinical nurse educator working in the adjacent lab was called to assist and made the decision to use the LUCAS 2 mechanical chest compression device to provide automatic external chest compressions. The radiolucent carbon fiber backboard was placed under Vanessa’s shoulders and the piston/suction cup placed over her chest. Once started, the LUCAS 2 applied continuous chest compressions of at least 5 centimeters at a consistent rate of 100 or more compressions per minute.

Home September 08, 2014
Home
Case Study

After several years of trials and increasing clinical use, transcatheter aortic valve replacement (TAVR) has reached a tipping point. It is quickly becoming the standard of care for ill patients suffering from aortic valve stenosis who are not eligible for open heart surgery. Implemented successfully, TAVR procedures improve outcomes and quality of life for patients while reducing costs for hospitals.

Home September 08, 2014
Home
Covidien TurboHawk Clinical Study Directional Atherectomy Effective PAD Therapy
Feature

Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien study published online in the Journal of American College of Cardiology, Cardiovascular Interventions (JACC CI).

Home September 08, 2014
Home
Subscribe Now